Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionLeuthold Group, Llc
Latest Disclosed Ownership56,091 shares
Latest Disclosed Value $ 7,817,403
Leuthold Group, Llc reports 1.88% increase in ownership of GILD / Gilead Sciences, Inc.

On May 6, 2026 - Leuthold Group, Llc filed a 13F-HR form disclosing ownership of 56,091 shares of Gilead Sciences, Inc. (CH:GILD) valued at $7,817,403 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 55,058 shares of Gilead Sciences, Inc.. This represents a change in shares of 1.88% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F Gilead Sciences COM 375558103 56,091 1,033 1.88 7,817 15.69 0.8327
2026-02-05 2025-12-31 13F Gilead Sciences COM 375558103 55,058 12,422 29.14 6,758 42.79 0.7298
2025-11-06 2025-09-30 13F Gilead Sciences COM 375558103 42,636 42,636 4,733 0.5178
2021-05-17 2021-03-31 13F Gilead Sciences COM 375558103 0 -43,597 -100.00 0 -100.00
2021-02-16 2020-12-31 13F Gilead Sciences COM 375558103 43,597 -44,613 -50.58 2,540 -54.43 0.3348
2020-11-16 2020-09-30 13F Gilead Sciences COM 375558103 88,210 -1,745 -1.94 5,574 -19.46 0.7641
2020-08-14 2020-06-30 13F Gilead Sciences COM 375558103 89,955 -2,261 -2.45 6,921 0.39 1.0306
2020-05-15 2020-03-31 13F Gilead Sciences COM 375558103 92,216 -7,612 -7.63 6,894 6.27 1.2422
2020-02-14 2019-12-31 13F Gilead Sciences COM 375558103 99,828 -3,803 -3.67 6,487 -1.23 0.8447
2019-11-14 2019-09-30 13F Gilead Sciences COM 375558103 103,631 35,703 52.56 6,568 43.12 0.8604
2019-08-14 2019-06-30 13F Gilead Sciences COM 375558103 67,928 -4,339 -6.00 4,589 -2.32 0.5918
2019-05-15 2019-03-31 13F Gilead Sciences COM 375558103 72,267 28,658 65.72 4,698 72.21 0.6320
2019-02-14 2018-12-31 13F Gilead Sciences COM 375558103 43,609 -3,032 -6.50 2,728 -24.24 0.3910
2018-11-14 2018-09-30 13F Gilead Sciences COM 375558103 46,641 46,641 3,601 0.3923
2018-05-15 2018-03-31 13F Gilead Sciences COM 375558103 0 -95,395 -100.00 0 -100.00
2018-02-14 2017-12-31 13F Gilead Sciences COM 375558103 95,395 23,508 32.70 6,834 17.34 0.6825
2017-11-14 2017-09-30 13F Gilead Sciences COM 375558103 71,887 -103 -0.14 5,824 14.31 0.5882
2017-08-14 2017-06-30 13F Gilead Sciences COM 375558103 71,990 -2,521 -3.38 5,095 0.67 0.5459
2017-05-15 2017-03-31 13F Gilead Sciences COM 375558103 74,511 -1,659 -2.18 5,061 -7.22 0.5453
2017-02-14 2016-12-31 13F Gilead Sciences COM 375558103 76,170 -5,883 -7.17 5,455 -15.97 0.6102
2016-11-14 2016-09-30 13F Gilead Sciences COM 375558103 82,053 82,053 0.00 6,492 0.6822
2016-08-15 2016-06-30 13F Gilead Sciences COM 375558103 0 -73,750 -100.00 0 -100.00
2016-05-16 2016-03-31 13F Gilead Sciences COM 375558103 73,750 21,473 41.08 6,775 28.07 0.7387
2016-02-12 2015-12-31 13F Gilead Sciences COM 375558103 52,277 15,934 43.84 5,290 48.22 0.5551
2015-11-16 2015-09-30 13F Gilead Sciences COM 375558103 36,343 -5,062 -12.23 3,569 -26.38 0.3770
2015-08-14 2015-06-30 13F Gilead Sciences COM 375558103 41,405 1,523 3.82 4,848 23.86 0.4535
2015-05-15 2015-03-31 13F Gilead Sciences COM 375558103 39,882 519 1.32 3,914 5.50 0.3635
2015-02-17 2014-12-31 13F Gilead Sciences COM 375558103 39,363 39,363 42.62 3,710 162.19 0.3645
2013-11-14 2013-09-30 13F Gilead Sciences COM 375558103 0 -27,599 -100.00 0 -100.00
2013-08-14 2013-06-30 13F Gilead Sciences COM 375558103 27,599 27,599 1,415 0.1311
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.